FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385108009: Conventional release cutaneous solution (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479370017 Cutaneous solution en Synonym Active Entire term case insensitive SNOMED CT core module
3558864015 Conventional release cutaneous solution (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3558865019 Conventional release cutaneous solution en Synonym Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous solution Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Is a Drug solution false Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has basic dose form Solution true Inferred relationship Existential restriction modifier
Conventional release cutaneous solution Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Conventional release solution for cutaneous spray Is a False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Carbol-fuchsin topical solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely efinaconazole 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydrogen peroxide 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine diacetate 200 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely phenol 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely phenol 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely aminolevulinic acid hydrochloride 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely podophyllotoxin 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 150 milligram/1 milliliter and chlorhexidine gluconate 15 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 22.5 milligram/1 milliliter and chlorhexidine gluconate 2.25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 1.5 milligram/1 milliliter and chlorhexidine gluconate 150 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely methylrosanilinium chloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 0.1% topical solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 250 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely silver nitrate 500 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Chlorhexidine gluconate 0.5% in 70% IMS solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 2% solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely sulconazole nitrate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Ciclopirox olamine 8% solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely haloprogin 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Fluorouracil 1% solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely halcinonide 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely aluminium chloride 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Fluorouracil 5% solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Chlorhexidine gluconate+ethyl alcohol 1%/61% solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Sodium hypochlorite 0.5% solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Iodine 0.7%/isopropyl alcohol 74% w/w topical solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely aluminium chloride 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cetrimide 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 50 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Cocaine viscous 10% conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Cocaine viscous 4% conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Sodium hypochlorite 8% conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely sodium hypochlorite 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Coal tar 40% conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Recombinant thrombin 20000iu powder for conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Bovine thrombin 20000iu powder for conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Bovine thrombin 5000iu powder for conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Recombinant thrombin 5000iu powder for conventional release cutaneous solution Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tioconazole 283 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Conventional release solution for iontophoresis Is a True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely cocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely triclosan 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely coal tar 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 170 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Conventional release cutaneous solution Inferred relationship Existential restriction modifier

Page 1 of 4 Next End

This concept is not in any reference sets

Back to Start